Literature DB >> 17346184

Anti-apoptotic actions of insulin-like growth factors: lessons from development and implications in neoplastic cell transformation.

Isabel Varela-Nieto1, Markus Hartl, Itziar Gorospe, Yolanda León.   

Abstract

Insulin-like growth factor-I (IGF-I) is widely expressed during development, and is actively involved in the regulation of cell growth, proliferation, and differentiation. Underlying these activities is the capacity of IGF-I to promote survival in a variety of cell types, including those of the nervous system. However, in adult tissues deregulation of the IGF system can cause undesired cell survival and therefore excessive cell proliferation. Here, we review the contribution of IGF-I in developmental processes with a focus on the development of the inner ear, as well as pathological implications resulting from IGF-I deregulation during cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346184     DOI: 10.2174/138161207780249164

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  6 in total

1.  Pregnancy-associated plasma protein (PAPP)-A expressed in the mammary gland controls epithelial cell proliferation and differentiation.

Authors:  Makoto Nakasato; Hitoshi Kohsaka; Tetsuya Mizutani; Gen Watanabe; Kazuyoshi Taya; Kentaro Nagaoka
Journal:  Endocrine       Date:  2012-08-17       Impact factor: 3.633

2.  Pegylated Insulin-Like Growth Factor 1 attenuates Hair Cell Loss and promotes Presynaptic Maintenance of Medial Olivocochlear Cholinergic Fibers in the Cochlea of the Progressive Motor Neuropathy Mouse.

Authors:  Linda Bieniussa; Baran Kahraman; Johannes Skornicka; Annemarie Schulte; Johannes Voelker; Sibylle Jablonka; Rudolf Hagen; Kristen Rak
Journal:  Front Neurol       Date:  2022-06-03       Impact factor: 4.086

3.  A comparative study of age-related hearing loss in wild type and insulin-like growth factor I deficient mice.

Authors:  Raquel Riquelme; Rafael Cediel; Julio Contreras; Rodriguez-de la Rosa Lourdes; Silvia Murillo-Cuesta; Catalina Hernandez-Sanchez; Jose M Zubeldia; Sebastian Cerdan; Isabel Varela-Nieto
Journal:  Front Neuroanat       Date:  2010-06-23       Impact factor: 3.856

4.  The role of insulin-like growth factor-I in the physiopathology of hearing.

Authors:  Silvia Murillo-Cuesta; Lourdes Rodríguez-de la Rosa; Rafael Cediel; Luis Lassaletta; Isabel Varela-Nieto
Journal:  Front Mol Neurosci       Date:  2011-07-25       Impact factor: 5.639

5.  AKT signaling mediates IGF-I survival actions on otic neural progenitors.

Authors:  Maria R Aburto; Marta Magariños; Yolanda Leon; Isabel Varela-Nieto; Hortensia Sanchez-Calderon
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

Review 6.  Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss.

Authors:  Gilda M Kalinec; Gwen Lomberk; Raul A Urrutia; Federico Kalinec
Journal:  Front Cell Neurosci       Date:  2017-07-07       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.